Drug Week articles from August 2004

Drug Week archives from August 2004

Heat-sensitive method tests effectiveness of allergy meds.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Summer can bring with it severe sneezing attacks and itching eyes. People who suffer from hay fever can tell you all about how sometimes a pack of tissues does not even last long enough for a short...

Enrollment closes in phase III trial with Phenserine.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Axonyx, Inc., (AXYX) announced that it has completed enrollment in the first of its two on-going phase III clinical studies evaluating Phenserine in patients with mild to moderate Alzheimer disease. ...

North American rights acquired for Andrin.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Ascend Therapeutics announced that it has secured exclusive North American development, marketing and commercialization rights to the developmental pharmaceutical product Andrin (transdermal...

CDC recommends resumption of third dose of Prevnar.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- The Centers for Disease Control and Prevention (CDC) has issued an updated recommendation that all healthy children under 24 months of age should receive at least 3 doses of Prevnar, Pneumococcal...

Company reports positive results from Periostat + Atridox study.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- CollaGenex Pharmaceuticals, Inc., (CGPI) announced the clinically and statistically significant results of a 6-month, 180-patient clinical trial designed to evaluate the safety and efficacy of Periostat...

Up-front cost for treating HIV-infected patient in Africa is US$30 per visit.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Researchers at Johns Hopkins and the Perinatal HIV Research Unit, University of Witwatersrand, South Africa, have determined that the actual average cost for providing primary care to an HIV-infected...

Novel FLT3 inhibitors may be considered to treat hyperdiploid or relapsed ALL.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Novel FLT3 inhibitors may be considered for the treatment of hyperdiploid or relapsed acute lymphoblastic leukemia. "Activating mutations of the FLT3 receptor tyrosine kinase are common in acute...

FLT3 mutations in AML adversely associate with CR with intensive chemotherapy.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- FLT3 mutations are adversely associated with complete remission in AML patients given intensive chemotherapy. "The prognostic impact of FLT3 mutations on the outcome of patients with diploid AML,...

Factors affecting good and poor CD34+ cell mobilization in AML determined.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- The factors affecting good and poor CD34+ cell mobilization in AML have been determined. According to a study from Italy, "The factors possibly affecting the collection of peripheral blood stem...

Timed sequential therapy for AML patients over 60 tolerated but unsatisfactory.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Timed sequential therapy for acute myeloid leukemia patients over 60 was well tolerated but unsatisfactory. "Acute myeloid leukemia (AML) in the elderly is a serious problem characterized by poor...

G protein regulators play key role in cocaine seeking.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- G protein regulators play key roles in cocaine seeking and neuroplasticity. "Chronic cocaine administration reduces G protein signaling efficacy. Here, we report that the expression of AGS3, which...

Flow cytometric method used to assess lipid accumulation in fat cells.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Researchers have used a simple flow cytometric method to assess lipid accumulation in fat cells. "Adipogenesis of preadipocytes in culture has been frequently used to study the molecular basis and...

Malignant adipose tissue tumors reviewed.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Researchers review malignant adipose tissue tumors in a recent issue of the Bulletin du Cancer. "Malignant adipose tissue tumors, also called liposarcomas, are the most common Sarcoma of adult...

University of Florida teams with Tufts on food and drug interactions.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- A new University of Florida (UF) research center is investigating how foods and drugs interact to prevent potentially harmful side effects and improve patient outcomes. The Center for Food-Drug...

Academy reacts to FDA alert on allergic reactions to pigment in permanent makeup.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- In response to the FDA's consumer alert regarding permanent makeup pigments that have been reported to cause severe allergic reactions, the American Academy of Micropigmentation wants consumers to...

FDA approves phase III study design for PreHistin.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- BioGentech Corp. (BGTH) has received a letter from the U.S. Food and Drug Administration (FDA) in which the FDA confirmed that two phase III study designs submitted by BioGentech for review effectively...

Novel approach to specific allergy treatment developed.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- The recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (RSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity....

Tentative approval granted for Allegra-D extended-release tablets.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Barr Pharmaceuticals, Inc., (BRL) announced that Barr Laboratories, Inc., has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Aventis...

Effect of citalopram on lymphocyte gene expression characterized.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- The effects of citalopram on lymphocyte gene expression have been characterized in cells from Alzheimer disease patients. "Antidepressants are widely used in the treatment of mood disorders...

Enoxaparin shows promise as therapy.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Enoxaparin shows promise as a treatment for Alzheimer disease. In a recent study, neurologists in Italy "investigated the effect of long-term, peripheral treatment with enoxaparin, a low molecular...

Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Researchers have found that a large protein, alsin, is a Rab5 and Rac1 guanine nucleotide exchange factor, and may play a role in a juvenile form of amyotrophic lateral sclerosis. "ALS2 is the gene...

Nerve cells' powerhouse "clogged" in Lou Gehrig disease.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- By studying rodent models of the relatively rare inherited form of Lou Gehrig disease and tissue samples from a patient with the condition, scientists have discovered the first evidence that damage to...

U.K. gives Cellegesic nod to treat chronic anal fissure pain.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Cellegy Pharmaceuticals, Inc., (CLGY) announced that the United Kingdom's Committee on Safety of Medicines (CSM) will recommend marketing authorization be granted by the Medicines and Healthcare...

Agreement with FDA reached on clinical development program for diltiazem.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- DOV Pharmaceutical, Inc., (DOVP) has reached agreement with the FDA's (U.S. Food and Drug Administration) Cardio-Renal Division on the scope and design of the clinical trials required for submission of...

Pathway of platelet procoagulant activity is regulated by IQGAP1.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- A shear-restricted pathway of platelet procoagulant activity is regulated by IQGAP1. According to a study from the United States, "Circulating blood platelets regulate the initial phase of the...

STI571 and taxol target skeletal compartment tumor-associated cells.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- STI571 and taxol target skeletal compartment tumor-associated cells. According to recent research from the United States, "the activation of the microvascular endothelial cell platelet-derived...

Meropenem lung penetration measured by microdialysis.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Microdialysis enables accurate and detailed measurements of antibiotic lung penetration. "Until recently, information on antibiotic pharmacokinetic properties in infected human lung tissue was...

Pharmacists highlight antibiotic misunderstanding and overuse in public survey.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- The Royal Pharmaceutical Society of Great Britain (RPSGB) highlighted the need for better understanding of how antibiotics work as part of the campaign to prevent antibiotic resistance. But a...

Role of mhc polymorphism in anti-microbial resistance reviewed.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Researchers review the role of mhc polymorphism in anti-microbial resistance in a recent issue of Microbes and Infection. According to published research from the United States, "The major...

Antioxidants prevent exercise-induced lipid peroxidation.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners. According to recent research from the United States, "To determine if 6...

Antipsychotics upregulate bcl-2 mRNA/protein in frontal cortex and hippocampus.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Antipsychotics upregulate bcl-2 mRNA and protein in the frontal cortex and hippocampus. "To investigate whether atypical antipsychotic drugs exert an effect on the neuroprotective protein Bcl-2,...

Styrylquinolines do not interfere with HIV entry but act before integration.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- SQLs do not interfere with HIV entry but act before integration. According to a study from France, "We have previously shown that styrylquinolines (SQLs) are integrase inhibitors in vitro. They...

New methods ease the separation of antisense oligonucleotide in plasma.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- New methods ease the separation of antisense oligonucleotide in plasma. "A novel approach is presented for the direct injection, and subsequent separation, of antisense phosphorothioate...

Serotonin transporter gene variation correlates with social phobia severity.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Serotonin transporter gene variation correlates with social phobia severity. "A functional polymorphism in the promoter region of the human serotonin transporter (5-HTT) gene has been related to...

Akt kinase activation blocks apoptosis in intestinal epithelial cells.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Akt kinase activation blocks apoptosis in intestinal epithelial cells by inhibiting caspase-3 after polyamine depletion. "Apoptosis plays a critical role in the maintenance of gut mucosal...

P300 regulates p53-dependent apoptosis in colorectal cancer cells.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- P300 nucleoprotein regulates p53-dependent apoptosis in colorectal cancer cells. "Activation of the tumor suppressor p53 by DNA damage induces either cell cycle arrest or apoptosis, but what...

Effectiveness of ablation for atrial fibrillation has not been established.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Randomized controlled trials are necessary to determine the long-term effectiveness of ablation for atrial fibrillation (AF). "During the past 10 years numerous studies on the treatment of...

Roles of IL-18 in collagen-induced arthritis investigated.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Researchers review the roles of interleukin-18 in collagen-induced arthritis in the BB rat in a recent issue of Clinical and Experimental Immunology. "Interleukin (IL)-18 is a member of the IL-1...

Vioxx in high doses causes hypertension.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- The evidence is growing: Chronic, high-dose consumption of the arthritis pain reliever Vioxx can raise blood pressure and the risk of serious heart problems. Yet a "substantial number" of patients...

Bovine collagen peptide vaccine modulates severity of arthritis.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis. According to a study from...

Thymosin alpha 1 activates dendritic cells for antifungal resistance.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling. "Dendritic cells (DCs) show a remarkable functional plasticity in the recognition of...

European approval sought for Xolair as treatment for severe allergic asthma.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Novartis Pharma AG has submitted its application for the European approval of Xolair. Xolair (omalizumab) is a novel therapy, which targets a root cause of allergic disease and offers an entirely...

Hundreds of athletes with asthma compete in Athens.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- A diagnosis of asthma used to mean a seat on the bench for amateur and professional athletes. But with advances in asthma treatment and management, asthma - not the athlete - is sent to the...

Physicians fail to prescribe proper medication for asthma patients.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- A U.S. study of treatment for asthma patients who visited the emergency department (ED) suggests that physicians are not following the recommended asthma guidelines and are underprescribing controller...

Oxidized lipids, antibodies may be markers for atherogenesis.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- The oxidation hypothesis of atherogenesis has been studied and researchers report new evidence that oxidized lipids and antibodies in those lipids may play a role as markers for atherogenesis. "The...

Low-density lipoprotein should be between 50 and 70 mg/dl.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Current guidelines for low-density lipoprotein (LDL) cholesterol should be between 50 and 70 mg/dl. "The normal LDL cholesterol range is 50 to 70 mg/dl for native hunter-gatherers, healthy human...

Some lipid-lowering drugs can stabilize atherosclerotic plaque.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- The fibrinolytic system and lipoproteins are related in the pathogenesis of coronary atherosclerosis. "The fibrinolytic system is comprised of a series of serine proteases and serine protease...

Statins promote collateral neovascularization without causing cancer growth.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Statins promote collateral neovascularization without causing cancer growth. According to a study from Japan, "3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, or statins, are widely...

U.S. pharmacy group to distribute nutritional supplement.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Australian Cancer Technology Limited (ACU) announced that its U.S. subsidiary, ACT (USA), has signed a distribution deal with Rochester Drug Cooperative, which will see the revisys range of nutritional...

Pharmaceutical innovation award program announced.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Microsoft Corp. (MSFT) announced the first Microsoft Pharmaceutical Innovation Award program, sponsored by Proscape Technologies Inc. Through this annual award, Microsoft will recognize the...

Non-electrophoretic assays screen for chemical inhibitors of DNA ligase.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Non-electrophoretic assays screen for chemical inhibitors of DNA ligase. "A new rapid assay method for DNA ligases has been developed, which allows direct quantification of enzyme activity without...

Nucleoside insertions stabilize oligonucleotides.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Nucleoside insertions stabilize oligonucleotides. According to a study from Denmark, "hexofuranosyl nucleosides are considered as conformationally restricted acyclic nucleosides using a furanose...

Oligonucleotides in human urine don't contain oxidized lesions.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Oligonucleotides in human urine don't contain oxidized lesions. According to a study from Denmark, "the promutagenic DNA modification 8-oxo-7,8-dihydrodeoxyguanosine is the most frequently used...

Imaging agent launched for preclinical computed tomography.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Alerion Biomedical, Inc., a company developing diagnostic and therapeutic products based on its molecular targeting technologies, has launched Fenestra, its first contrast enhancement product line for...

Biosensors identify DNA binding at the single molecular level.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Biosensors identify DNA binding at the single molecular level. According to published research from Japan, "a novel method for detecting interaction between DNA and DNA-binding protein at the...

Congress OKs bill to create vaccines, antidotes to biological, chemical weapons.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Enough new-generation anthrax vaccine to dose 25 million people: That's first on the U.S. government's shopping list under a massive new program to develop and stockpile antidotes to biological and...

BLM and CAF-1 coordinate to promote survival in response to DNA damage.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- BLM and CAF-1 coordinate to promote survival in response to DNA damage. According to recent research published in the journal Molecular and Cellular Biology, "Bloom's syndrome (BS) is a genomic...

Local gene therapy improves bone deposition during distraction osteogenesis.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Local gene therapy improves bone deposition during distraction osteogenesis. "Distraction osteogenesis (DO) requires a long consolidation period and has a low but real failure rate. Bone morphogenic...

PCL-TCP scaffolds seeded with osteoblasts sustains osteogenic expression.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Poly-caprolactone 20% tricalcium phosphate scaffolds seeded with osteoblasts sustains excellent osteogenic expression. According to published research from Singapore, "Our strategy entails...

PRDC is a potent BMP antagonist with a wide tissue expression pattern.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Protein related to DAN and cerberus (PRDC) is a potent bone morphogenetic protein antagonist with a wide tissue expression pattern. "Bone morphogenetic proteins (BMPs) are important for body...

Vaccination with botulinum neurotoxin fragments prevents botulism.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Vaccination with botulinum neurotoxin fragments prevents botulism. "Mice and ducks were subcutaneously immunized with recombinant whole heavy (H) chains of Clostridium botulinum type C and D...

Vaccine targeting cancer-related antigens appears to prolong survival.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Researchers seeking to direct cancer-killing immune cells against the deadliest brain tumors have three new targets that show promise in laboratory studies and in a Phase I patient trial, according to...

Cancer therapeutics development company files IND for metastatic breast cancer.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- NeoRx Corporation (Nasdaq:NERX) announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a phase II clinical study of STR (skeletal...

ER codon 594/HER2 codon 655 polymorphisms not associated with breast cancer risk.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- ER codon 594 and HER2 codon 655 polymorphisms are not associated with an increased breast cancer risk. According to a study from Turkey, "The estrogen receptor (ER) and the human epithelial growth...

Increased serum folate levels associated with reduced breast cancer risk.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Increased serum folate levels are associated with reduced breast cancer risk. "Breast cancer risk may be associated with folate status or the C677T genotype of the methylenetetrahydrofolate...

Novel phosphorylation sites in HMGN1 protein from breast cancer cells identified.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Novel phosphorylation sites in high-mobility group N1 protein from breast cancer cells have been identified. According to recent research published in the journal Biochemistry, "High-mobility group...

Tamoxifen metabolite R-isomer forms more DNA adducts in liver cells.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- A tamoxifen metabolite R-isomer forms more DNA adducts in liver cells. "The antiestrogenic drug tamoxifen forms DNA adducts in rat liver through two genotoxic metabolites, a-hydroxytamoxifen and...

Slow release rate optimal for pegylated liposomal doxorubicin.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Slow release rates produce optimal results with pegylated liposomal doxorubicin. In a recent study from Canada, the "pharmacokinetics (PK), biodistribution (BD), and therapeutic activity of...

Buruli ulcer disease in Cameroon rediscovered.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Researchers have rediscovered Buruli ulcer disease in Cameroon. According to published research from Cameroon and Belgium, "To assess the magnitude of the Buruli ulcer (BU) problem in Cameroon, we...

Medical technology company lists on London AIM Exchange, reports on options.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Norwood Abbey Ltd. (OTC:NABYF) (ASX:NAL) advises that the securities of its subsidiary Norwood Immunology Ltd (NIM) have commenced trading on London's Alternative Investment Market (AIM:NIM). The...

Personal care products marketer applies for NASDAQ national market listing.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Natural Health Trends Corp. (OTC BB: NHLC) announced that it filed an application during the second quarter of 2004 to list the company's common stock on the NASDAQ National Market System. Mark...

Pharma company announces exercise of over allotment option.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Pharmion Corporation (NASDAQ:PHRM) announced that the underwriters of its previously announced offering of common stock have exercised in full their over allotment option and agreed to purchase an...

Pharmaceutical company added to Russell 2000 Index.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Pharmos Corporation (NASDAQ:PARS) announced that the company has been added to the Russell 2000 Index, a subset of the Russell 3000 Index. The Russell 3000 comprises 3,000 of the largest U.S....

Pharmaceutical group announces that joint venture is operational.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Hubei Pharmaceutical Group (HBEI) announced that its new joint venture, a 60% controlling interest in Hubei Tongji Benda Ebei Pharmaceutical Co. Ltd. (HBBendaJV), located in Guangshui City, Hubei...

Alprox-TD license, supply and distribution agreement signed with Schering.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- NexMed, Inc., (NASDAQ:NEXM) announced that it has entered into a license, supply and distribution agreement with Schering AG, Germany (NYSE: SHR; FSE: SCH). This agreement provides Schering with...

Approval received to market Lyrica in Europe.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Pfizer Inc said that it has received approval from the European Commission to market Lyrica (pregabalin) in all European Union member states for the treatment of peripheral neuropathic pain and as an...

Biopharmaceutical company announces contract with GlaxoSmithKline.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- ProMetic Life Sciences Inc. (TSX: PLI) announced that its wholly owned subsidiary ProMetic BioSciences Ltd. has signed a contract with GlaxoSmithKline (GSK) to provide GSK access to ProMetic's unique...

Biosafety lab expansion, patent issuance and biodefense reagents sale announced.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Commonwealth Biotechnologies, Inc., (NASDAQ: CBTE) announced completion of its new virology biosafety level 3 laboratory within its accredited BSL-3 suite. Construction and fit-out of the new lab...

Biotech firm establishes new international headquarters.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Biogen Idec (BIIB) officially opened its new international headquarters in Zug, Switzerland. With its global commercial and administrative operations headquartered in Switzerland, Biogen Idec will...

Certificate of Suitability granted for Cephradine.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) announced that it has been granted the Certificate of Suitability (CoS) by the European Directorate for the Quality of Medicines (EDQM) for its API...

Decapinol approved in EU; Aloclair Gel approved in U.S.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Sinclair Pharma, plc, has received regulatory approvals for two of its key products, Decapinol and Aloclair Gel, and also provided a year-end trading update in advance of its preliminary results for the...

Drug discovery company spins off peptide technologies business unit.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Jerini AG has transferred its peptide technologies business unit to a wholly owned subsidiary to ensure further growth and increased market penetration. Under the direction of former business unit...

FDA approval granted for new biopharmaceutical production plant.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- Boehringer Ingelheim has received official approval for its new biopharmaceutical active ingredients production plant following an inspection of the plant at the Biberach (Riss) site by the U.S. Food...

First payment made in Therapik multi-year agreement.
August 6, 2004... 2004 AUG 6 - (NewsRx.com & NewsRx.net) -- The Jenex Corporation (JEN) has received their first payment of $77,500 from the previously announced exclusive multi-year agreement with Daeyang E&C of Korea. Daeyang will manufacture and market...